Citadel Advisors
ALIM

Citadel Advisors’s Alimera Sciences ALIM Stock Holding History

Citadel Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-993
Closed -$22K – 7976
2016
Q3 		$22K Buy
+993
New +$22.9K ﹤0.01% 7023
2015
Q2 		– Sell
-107
Closed -$8K – 9164
2015
Q1 		$8K Buy
107
+20
+23% +$1.57K ﹤0.01% 8249
2014
Q4 		$7K Sell
87
-760
-90% -$61.7K ﹤0.01% 8214
2014
Q3 		$69K Sell
847
-166
-16% -$14.2K ﹤0.01% 6684
2014
Q2 		$91K Buy
1,013
+813
+407% +$72.2K ﹤0.01% 6303
2014
Q1 		$24K Buy
+200
New +$19.4K ﹤0.01% 7212

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Citadel Advisors's ALIM Position: Q2 2024 in Review

Citadel Advisors sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 28,871 shares — an estimated $113K sold.

Citadel Advisors first reported a position in ALIM in Q1 2014 and held it in 15 quarters. The position peaked at $113K in Q1 2024. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Citadel Advisors reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 28,871 Alimera Sciences shares in Q2 2024, an estimated $113K.
  • Citadel Advisors first reported a position in Alimera Sciences in Q1 2014 and held it in 15 quarters.
  • Citadel Advisors's Alimera Sciences position peaked at $113K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.